Home Featured Page 82

Featured

It is no secret that corporate venture capital is on an upswing. Last year, corporate investors participated in nearly 1,200 transactions nationwide with an accumulative deal value of more than $32 billion. While this was down slightly from an even more active 2015, it was more than double the deal volume of six years earlier. […]
Worldwide venture capital investments into solar energy technology have dipped in 2017, with both deal count and total equity invested down from last year. As of late June, investors have given $254 million in 21 deals to companies in the solar industry this year, compared to $813 million over 102 deals last year, according to […]
Canada’s life sciences sector is on a roll. Current levels of venture capital investment are unprecedented. This week another major deal was announced, with Repare Therapeutics, a Montréal developer of precision oncology drugs, securing about $90 million in a Series A financing. One of the sector’s other big stories is the IPO of biotherapeutics provider Zymeworks. The company, which last month raised about $86 million on the Toronto and New York exchanges, is now being talked about as Canada’s next biotech anchor company.
Venture capitalists convening in Washington for the White House summit called “tech week” will meet on Thursday with President Trump and discuss such emerging technologies as drones and the Internet of Things, according to a senior White House official. The American Leadership in Emerging Technology summit on June 22 will feature breakout sessions on the […]
By Jeff Harbach, Kauffman Fellows For too long, venture capital investment decisions have been purely subjective, with investors relying on only gut instinct and pattern recognition to select which startups to fund. Just as often, the people who are funded tend to look a whole lot like one another. But today, a new generation of […]
The jury, you might say, is still out for Correlation Ventures. In 2012, the San Diego venture firm started taking a novel approach to investing. In its investment decisions, the firm uses predictive analytics software to find the next all-star and help with deal making. After five years, Correlation Managing Partner David Coats said he […]
Venture capital investments in U.S.-based cannabis-related startups have dropped in 2017 compared to the two years before. As of mid-June, four cannabis or medical marijuana startups have raised $7.73 million from venture investors, compared to eight companies in 2016 that raised $36.65 million, according to VCJ’s analysis of Thomson Reuters data. U.S. investments cannabis startups […]
By Alex Derber, VCJ Correspondent For all the talk about startups with global aspirations, North American companies usually make Europe their first port of call, and vice-versa. Similar legal systems, language and culture justify this move, but some investors are heading in a different direction: China. Atlantic Bridge of Dublin, for instance, has a $100 million […]
Funds from Softbank Capital, Fairview Capital and Performance Equity Management top of a portfolio of mid-decade venture funds at the New York State and Local Retirement System. The portfolio, with vintages of 2002 to 2006, favors mid-sized funds employing a multi-stage investment strategy. The holdings include three funds of funds. Nearly half of the funds […]
The legal clashes over beach access at the site of venture capitalist Vinod Khosla’s property have resumed, with two separate cases being heard in June. Attorneys for Khosla appeared before a panel of state appellate justices in San Francisco on June 15 to present arguments related to the public-access dispute. A hearing for a related […]
vcj
vcj

Copyright PEI Media

Not for publication, email or dissemination